Showing 25 of 25 results
Number of displayed results:
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in activated T-helper 17 cellMus musculus strain C57BL/6NJ activated T-helper 17 cell genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in activated CD4-positive, CD25-positive, alpha-beta regulatory T cellMus musculus strain C57BL/6NJ activated CD4-positive, CD25-positive, alpha-beta regulatory T cell genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in activated T-helper 17 cellMus musculus strain C57BL/6NJ activated T-helper 17 cell genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in activated T-helper 2 cellMus musculus strain C57BL/6NJ activated T-helper 2 cell genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in activated T-helper 1 cellMus musculus strain C57BL/6NJ activated T-helper 1 cell genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in activated naive CD4-positive, alpha-beta T cellMus musculus strain C57BL/6NJ activated naive CD4-positive, alpha-beta T cell genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM ZK216348 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM ZK216348 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM RU486 (antagonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM RU486 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM Mapracorat for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM Hydrocortisone (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM Hydrocortisone for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM GW870086 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM GW870086 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfectionLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM dexamethasone (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM dexamethasone (CHEBI:41879) for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM CpdA for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM CORT108297 (antagonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM CORT108297 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM AZD9567 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM AZD9567 for 4 hours
- STARR-seq in A549Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM AZD2906 (agonist) for 4 hoursLab: Tim Reddy, DukeProject: ENCODETreatment: 1 μM AZD2906 for 4 hours
- CRISPRi proliferation screen in OCI-AML2CRISPR-dCas9-based epigenomic regulatory element screening (CERES) technology to screen a subset of putative non-coding regulatory elements identified in human K562 leukemia cells from whole genome discovery screen (validation). This validation screen was performed in OCI-AML2 acute myeloid leukemia cellsTiling modality: sparse peakLab: Tim Reddy, DukeProject: ENCODE
- CRISPRi proliferation screen in K562CRISPR-dCas9-based epigenomic regulatory element screening (CERES) technology to screen a subset of putative non-coding regulatory elements identified in human K562 leukemia cells from whole genome discovery screen (validation). This validation screen was performed in K562 leukemia cellsTiling modality: sparse peakLab: Tim Reddy, DukeProject: ENCODE
- CRISPRi proliferation screen in K562CRISPR-dCas9-based epigenomic regulatory element screening (CERES) technology to screen all >100,000 putative non-coding regulatory elements defined by open chromatin sites in human K562 leukemia cells for their role in regulating essential cellular processes (whole genome).Tiling modality: peak tilingLab: Tim Reddy, DukeProject: ENCODE
- perturbation followed by scRNA-seq in K562Homo sapiens K562 genetically modified (insertion) using transduction, using CRISPRi (sgRNA)Lab: Tim Reddy, DukeProject: ENCODELibrary construction platform: 10X Genomics Chromium Controller
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionLab: Tim Reddy, DukeProject: ENCODE
- STARR-seq in K562Homo sapiens K562 genetically modified (episome) using transient transfectionElements selection method: accessible genome regionsLab: Tim Reddy, DukeProject: ENCODE